All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.


Outcomes of in vitro fertilization in infertile patients with early-stage endometrial cancer or atypical endometrial hyperplasia: an analysis of 31 cases

Aim: To assess the effectiveness of intracytoplasmic sperm injection (ICSI) or in vitro fertilization (IVF) and embryo transfer (IVF-ET) in infertile patients with early-stage endometrial cancer (EC) or atypical endometrial hyperplasia (AEH).

Methods: Patients with well-differentiated, early-stage EC or AEH who achieved complete reversion of the endometrium after conservative treatment and who underwent IVF-ET between January 2012 and December 2015 were collected. Fertilization rate, implantation rate, pregnancy rate and AEH/EC recurrence rate were measured.

Results: A total of 31 patients were included, of whom 25 (80.65%) had AEH and 6 (19.35%) had well-differentiated early-stage EC. Mean duration of conservative treatment was 8.25±4.08 months, while mean age at entering the IVF cycle was 34.9±3.8 years. The average number of embryos transferred was 1.7 ± 0.8. The IVF and ICSI fertilization rates were 77.6% and 68.2%, respectively. The implantation and pregnancy rates were 29.6% (16/54) and 41.9% (13/31), respectively. There were 13 cases of intrauterine pregnancy with a clinical pregnancy rate of 41.9%. Recurrence of endometrial lesion occurred in 2 (6.45%) patients.

Conclusions: Assisted reproductive technology is a good option in well-selected patients with early-stage EC or AEH who show complete reversion of the endometrial lesion after conservative therapy.

Author(s): Yuanzheng Zhou, Shengyuan Ran, Ling Weng, Chengyan Deng, Fangfang He, Zhengyi Sun, Hanbi Wang, Jingran Zhen1, Qi Yu

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+